Ruijin Hospital: Colorectal Neoplasms trials

The registry lists 12 Colorectal Neoplasms studies with Ruijin Hospital as lead sponsor. 4 are open to participants now and 0 have results posted.

Early Phase 1 1Phase 1 1Phase 2 4Phase 3 4Phase 4 1No phase 5(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Postoperative Circulating Tumor DNA Monitoring in Stage I-III Driver-Mutant Colon AdenocarcinomaRecruitingNCT07795528
• Study on the Safety and Tolerability of PD-1 Knockout Tumor-infiltrating T Cells (TILs) in the Treatment of Advanced Colorectal CancerRecruitingNCT07035002Phase 1
• The Role of 18F-FDG and 68Ga-FAPI PET/CT in the Diagnosis and the Efficacy Evaluation of Advanced Colorectal Cancer (peritoneal Metastasis With/without Other Metastases)RecruitingNCT06601075
• Oncologic Outcomes of Single-incision Versus Conventional Laparoscopic Surgery for Colorectal CancerRecruitingNCT04527861Not applicable
• A Clinical Research of CAR T Cells Targeting CEA Positive Colorectal Cancer (CRC)Status unknownNCT04513431Early Phase 1
• Single-incision Versus Conventional Laparoscopic Surgery for Colorectal CancerWithdrawnNCT03633539Not applicable
• Three-port Versus Conventional Laparoscopic Surgery for Colorectal CancerStatus unknownNCT03426514Not applicable
• Biological-guided Metronomic Chemotherapy as Maintenance Strategy in Metastatic Colorectal CancerTerminatedNCT03158610Phase 2/3
• Cetuximab Monotherapy Maintenance Treatment in mCRCStatus unknownNCT02978313Phase 2/3
• Cetuximab Maintenance Treatment Versus Continuation After Induction Therapy in mCRCStatus unknownNCT02942706Phase 2/3
• Metronomic Versus Conventional Chemotherapy in as Maintenance Treatment in mCRCStatus unknownNCT02893540Phase 2/3
• Maintenance Treatment With Capecitabine Metronomic Chemotherapy and Chinese Traditional Medicine in Metastatic Colorectal CancerStatus unknownNCT02575378Phase 4